Article
Multiplex profiling identifies clinically relevant signalling proteins in an isogenic prostate cancer model of radioresistance
22 Nov 2019
Abstract excerpt
The exact biological mechanism governing the radioresistant phenotype of prostate tumours at a high risk of recurrence despite the delivery of advanced radiotherapy protocols remains unclear. This study analysed the protein expression profiles of a previously generated isogenic 22Rv1 prostate cancer model of radioresistance using DigiWest multiplex protein profiling for a selection of 90 signalling proteins....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
